These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 20374330

  • 1. Reduced bone density in patients on long-term warfarin.
    Rezaieyazdi Z, Falsoleiman H, Khajehdaluee M, Saghafi M, Mokhtari-Amirmajdi E.
    Int J Rheum Dis; 2009 Jul; 12(2):130-5. PubMed ID: 20374330
    [Abstract] [Full Text] [Related]

  • 2. Reduced bone density in children on long-term warfarin.
    Barnes C, Newall F, Ignjatovic V, Wong P, Cameron F, Jones G, Monagle P.
    Pediatr Res; 2005 Apr; 57(4):578-81. PubMed ID: 15695604
    [Abstract] [Full Text] [Related]

  • 3. Vitamin K deficiency from long-term warfarin anticoagulation does not alter skeletal status in male rhesus monkeys.
    Binkley N, Krueger D, Engelke J, Suttie J.
    J Bone Miner Res; 2007 May; 22(5):695-700. PubMed ID: 17295605
    [Abstract] [Full Text] [Related]

  • 4. Decreased axial and peripheral bone density in patients taking long-term warfarin.
    Philip WJ, Martin JC, Richardson JM, Reid DM, Webster J, Douglas AS.
    QJM; 1995 Sep; 88(9):635-40. PubMed ID: 7583077
    [Abstract] [Full Text] [Related]

  • 5. Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.
    Avila ML, Pullenayegum E, Williams S, Shammas A, Stimec J, Sochett E, Marr K, Brandão LR.
    Osteoporos Int; 2016 Apr; 27(4):1547-1557. PubMed ID: 26572757
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density in patients given oral vitamin K antagonists.
    Lafforgue P, Daver L, Monties JR, Chagnaud C, de Boissezon MC, Acquaviva PC.
    Rev Rhum Engl Ed; 1997 Apr; 64(4):249-54. PubMed ID: 9178397
    [Abstract] [Full Text] [Related]

  • 7. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease.
    Donovan DS, Papadopoulos A, Staron RB, Addesso V, Schulman L, McGregor C, Cosman F, Lindsay RL, Shane E.
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1892-9. PubMed ID: 9620924
    [Abstract] [Full Text] [Related]

  • 8. Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation.
    Sato Y, Honda Y, Kunoh H, Oizumi K.
    Stroke; 1997 Dec; 28(12):2390-4. PubMed ID: 9412619
    [Abstract] [Full Text] [Related]

  • 9. The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study.
    Douketis JD, Ginsberg JS, Burrows RF, Duku EK, Webber CE, Brill-Edwards P.
    Thromb Haemost; 1996 Feb; 75(2):254-7. PubMed ID: 8815571
    [Abstract] [Full Text] [Related]

  • 10. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants.
    Pearson DA.
    Nutr Clin Pract; 2007 Oct; 22(5):517-44. PubMed ID: 17906277
    [Abstract] [Full Text] [Related]

  • 11. Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats.
    Haffa A, Krueger D, Bruner J, Engelke J, Gundberg C, Akhter M, Binkley N.
    J Bone Miner Res; 2000 May; 15(5):872-8. PubMed ID: 10804016
    [Abstract] [Full Text] [Related]

  • 12. Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss.
    Nguyen TV, Sambrook PN, Eisman JA.
    J Bone Miner Res; 1997 Jan; 12(1):124-35. PubMed ID: 9240735
    [Abstract] [Full Text] [Related]

  • 13. Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy.
    Avgeri M, Papadopoulou A, Platokouki H, Douros K, Rammos S, Nicolaidou P, Aronis S.
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):592-7. PubMed ID: 18799935
    [Abstract] [Full Text] [Related]

  • 14. Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
    Panico A, Lupoli GA, Fonderico F, Marciello F, Martinelli A, Assante R, Lupoli G.
    Thyroid; 2009 May; 19(5):437-42. PubMed ID: 19415993
    [Abstract] [Full Text] [Related]

  • 15. Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.
    Florkowski CM, Brownlie BE, Elliot JR, Ayling EM, Turner JG.
    N Z Med J; 1993 Oct 27; 106(966):443-4. PubMed ID: 8233173
    [Abstract] [Full Text] [Related]

  • 16. Comparison of bone mineral density with dual energy x-ray absorptiometry, quantitative ultrasound and single energy x-ray absorptiometry.
    El-Desouki MI, Sherafzal MS, Othman SA.
    Saudi Med J; 2005 Sep 27; 26(9):1346-50. PubMed ID: 16155646
    [Abstract] [Full Text] [Related]

  • 17. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.
    Targownik LE, Lix LM, Leung S, Leslie WD.
    Gastroenterology; 2010 Mar 27; 138(3):896-904. PubMed ID: 19931262
    [Abstract] [Full Text] [Related]

  • 18. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L.
    Am J Med; 1996 Sep 27; 101(3):262-9. PubMed ID: 8873487
    [Abstract] [Full Text] [Related]

  • 19. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM.
    Epilepsia; 2013 Nov 27; 54(11):1997-2004. PubMed ID: 24010637
    [Abstract] [Full Text] [Related]

  • 20. Single-point assessment of warfarin use and risk of osteoporosis in elderly men.
    Woo C, Chang LL, Ewing SK, Bauer DC, Osteoporotic Fractures in Men Study Group.
    J Am Geriatr Soc; 2008 Jul 27; 56(7):1171-6. PubMed ID: 18547361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.